Cargando…
First person – Carmen Hernández-Ainsa
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Carmen Hernández-Ainsa is first author on ‘ Development and characterization of cell models...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906168/ http://dx.doi.org/10.1242/dmm.049434 |
_version_ | 1784665351193100288 |
---|---|
collection | PubMed |
description | First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Carmen Hernández-Ainsa is first author on ‘ Development and characterization of cell models harbouring mtDNA deletions for in vitro study of Pearson syndrome’, published in DMM. Carmen is a research assistant in the lab of Eduardo Ruiz-Pesini at Universidad de Zaragoza, Zaragoza, Spain, investigating mitochondrial DNA deletions, pathological consequences and treatments through development of new in vitro models. |
format | Online Article Text |
id | pubmed-8906168 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-89061682022-03-09 First person – Carmen Hernández-Ainsa Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Carmen Hernández-Ainsa is first author on ‘ Development and characterization of cell models harbouring mtDNA deletions for in vitro study of Pearson syndrome’, published in DMM. Carmen is a research assistant in the lab of Eduardo Ruiz-Pesini at Universidad de Zaragoza, Zaragoza, Spain, investigating mitochondrial DNA deletions, pathological consequences and treatments through development of new in vitro models. The Company of Biologists Ltd 2022-03-01 /pmc/articles/PMC8906168/ http://dx.doi.org/10.1242/dmm.049434 Text en © 2022. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | First Person First person – Carmen Hernández-Ainsa |
title | First person – Carmen Hernández-Ainsa |
title_full | First person – Carmen Hernández-Ainsa |
title_fullStr | First person – Carmen Hernández-Ainsa |
title_full_unstemmed | First person – Carmen Hernández-Ainsa |
title_short | First person – Carmen Hernández-Ainsa |
title_sort | first person – carmen hernández-ainsa |
topic | First Person |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906168/ http://dx.doi.org/10.1242/dmm.049434 |